Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Clinical trial NCT05875428 · UNKNOWN

Trial details

NCT number: NCT05875428
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2023-07-10
Primary completion: 2024-12-31
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.